Genitourinary Cancer
Showing 1 - 25 of >10,000
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)
Recruiting
- Colitis
- +8 more
- Fecal Microbiota Transplantation
- Loperamide
-
Houston, TexasM D Anderson Cancer Center
Oct 17, 2022
Chemotherapy-Induced Nausea in Genitourinary Cancer and Changes
Not yet recruiting
- Bladder Cancer
- +2 more
- Blood and Tissue
-
Jacksonville, Florida
- +2 more
Apr 6, 2023
Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy
Recruiting
- Urothelial Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Impact of COVID-19 on GU Disease
Recruiting
- COVID-19 Infection
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 13, 2022
Fear of Cancer Recurrence in Genitourinary Cancer
Recruiting
- Fear of Cancer Recurrence
- +4 more
- FCR7 questionnaire
-
Munich, Bavaria, GermanyLudwig-Maximilian-Universität
Apr 5, 2022
Breast Cancer, Genitourinary Syndrome of Menopause Trial in Miami (Platelet-rich plasma (PRP))
Not yet recruiting
- Breast Cancer
- Genitourinary Syndrome of Menopause
- Platelet-rich plasma (PRP)
-
Miami, FloridaUniversity of Miami
Mar 31, 2023
Genitourinary Syndrome of Menopause Trial in Randers (SmartXIDE2V2LR, Monalisa Touch, DEKA, Florence, Italy)
Not yet recruiting
- Genitourinary Syndrome of Menopause
- SmartXIDE2V2LR, Monalisa Touch, DEKA, Florence, Italy
-
Randers, DenmarkDepartment of Obstetrics and Gynaecology, Randers Regional Hospi
Aug 17, 2023
Cancer, Severe Major Depression, Schizophrenia Trial (Virtual Cancer and Mental Health Tumor Board)
Not yet recruiting
- Cancer
- +8 more
- Virtual Cancer and Mental Health Tumor Board
- (no location specified)
Apr 26, 2023
Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer Trial in Boston (Clinician Nudge Email, Patient Nudge Letter and
Enrolling by invitation
- Breast Cancer
- +4 more
- Clinician Nudge Email
- Patient Nudge Letter and Share questionaire
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)
Recruiting
- Genitourinary Cancer
- +7 more
-
La Jolla, California
- +5 more
Jul 5, 2022
Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)
Recruiting
- Prostate Cancer
- +3 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron
Not yet recruiting
- Prostate Cancer
- +2 more
- Copper-64 labeled Granzyme B (64Cu-GRIP B)
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 7, 2023
Gender Related Coping and Survivorship for Genitourinary Cancers
Recruiting
- Bladder Cancer
- Additional Education
- +2 more
-
Washington, District of Columbia
- +1 more
Jan 23, 2023
Integrated Molecular Profiling in Advanced Cancers Trial
Active, not recruiting
- Breast Cancer
- +9 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Sep 26, 2022
Metastatic Cancer, Locally Advanced Cancer, Thoracic Cancer Trial in New York (Weekly 45 minute Sessions)
Active, not recruiting
- Metastatic Cancer
- +5 more
- Weekly 45 minute Sessions
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 19, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Reconstitution ofHuman Immune System inPatient Derived Xenograft
Suspended
- Genito Urinary Cancer
- +3 more
- Bone marrow biopsy
- Tumor biopsy
-
Durham, North CarolinaDuke University Medical Center
Nov 17, 2022
Bladder Cancer Trial in Athens (Durvalumab)
Active, not recruiting
- Bladder Cancer
- Durvalumab
-
Athens, Attica, GreeceHellenic GenitoUrinary Cancer Group
Mar 22, 2022
Bladder Cancer Trial in Athens (Nivolumab, chemoradiotherapy)
Recruiting
- Bladder Cancer
- Nivolumab
- chemoradiotherapy
-
Athens, Attica, GreeceHellenic GenitoUrinary Cancer Group
Mar 22, 2022
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of
Not yet recruiting
- Bone Metastases
- Urogenital Cancer
- Tc-99m MDP and gamma camera
- (no location specified)
Oct 26, 2022
Toripalimab, First-line Treatment Trial in Guangzhou (EP/EC+PD-1)
Recruiting
- Toripalimab
- First-line Treatment
-
Guangzhou, Guangdong, ChinaSun Yat-sen University cancer center
Mar 7, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +23 more
- Quality-of-Life Assessment
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 9, 2022
Breast Cancer Female, Genitourinary Syndrome of Menopause Trial (Microablative Fractional CO2 Laser Therapy)
Withdrawn
- Breast Cancer Female
- Genitourinary Syndrome of Menopause
- Microablative Fractional CO2 Laser Therapy
- (no location specified)
Oct 11, 2022